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We used cultured hippocampal neurons to determine the signaling pathways mediating
brain-derived neurotrophic factor (BDNF) regulation of spontaneous glutamate and
GABA release. BDNF treatment elevated calcium concentration in presynaptic terminals;
this calcium signal reached a peak within 1 min and declined in the sustained presence
of BDNF. This BDNF-induced transient rise in presynaptic calcium was reduced by
SKF96365, indicating that BDNF causes presynaptic calcium influx via TRPC channels.
BDNF treatment increased the frequency of miniature excitatory postsynaptic currents
(mEPSCs). This response consisted of two components: a transient component that
peaked within 1 min of initiating BDNF application and a second component that was
sustained, at a lower mEPSC frequency, for the duration of BDNF application. The initial
transient component was greatly reduced by removing external calcium or by treatment
with SKF96365, as well as by Pyr3, a selective blocker of TRPC3 channels. In contrast,
the sustained component was unaffected in these conditions but was eliminated by
U0126, an inhibitor of the MAP kinase (MAPK) pathway, as well as by genetic deletion
of synapsins in neurons from a synapsin triple knock-out (TKO) mouse. Thus, two
pathways mediate the ability of BDNF to enhance spontaneous glutamate release: the
transient component arises from calcium influx through TRPC3 channels, while the
sustained component is mediated by MAPK phosphorylation of synapsins. We also
examined the ability of these two BDNF-dependent pathways to regulate spontaneous
release of the inhibitory neurotransmitter, GABA. BDNF had no effect on the frequency
of spontaneous miniature inhibitory postsynaptic currents (mIPSCs) in neurons from
wild-type (WT) mice, but surprisingly did increase mIPSC frequency in synapsin TKO
mice. This covert BDNF response was blocked by removal of external calcium or by
treatment with SKF96365 or Pyr3, indicating that it results from calcium influx mediated
by TRPC3 channels. Thus, the BDNF-activated calcium signaling pathway can also
enhance spontaneous GABA release, though this effect is suppressed by synapsins
under normal physiological conditions.
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INTRODUCTION
The neurotrophin brain-derived neurotrophic factor (BDNF)
plays multiple roles in neuronal development, synapse
maturation and synaptic plasticity (Park and Poo, 2013). In
addition to its long-term developmental effects, BDNF acutely
affects synaptic transmission and other neuronal physiological
properties (Lessmann et al., 1994; Kang and Schuman, 1995;
Levine et al., 1995; Gottschalk et al., 1998; Li et al., 1998;
Mizoguchi et al., 2003; Amaral and Pozzo-Miller, 2007a;
McGurk et al., 2011). The most prominent acute effect of
BDNF is to increase the frequency of miniature excitatory
postsynaptic currents (mEPSCs; Li et al., 1998; Taniguchi et al.,
2000; Tyler and Pozzo-Miller, 2001), indicating an enhancement
of spontaneous glutamate release from presynaptic terminals.
In addition, BNDF has been shown to variably regulate the
presynaptic GABA release, either having no effect (Shinoda
et al., 2014; Colino-Oliveira et al., 2016), increasing (Bolton et al.,
2000; Wardle and Poo, 2003), or decreasing (Brünig et al., 2001)
the frequency of spontaneous miniature inhibitory postsynaptic
currents (mIPSCs).
The signaling mechanisms underlying the presynaptic actions
of BDNF remain elusive. Upon binding to trkB receptors,
BDNF activates multiple downstream signaling molecules,
including phospholipase C (PLC), MAP kinase (MAPK) and
PI3K (Reichardt, 2006). In turn, the substrates of these
kinases are largely responsible for carrying out the signaling
actions of BDNF. Several studies have reported that BDNF
increases intracellular calcium levels, which could underlie the
enhancement of spontaneous glutamate release (Li et al., 1998;
Boulanger and Poo, 1999; Pozzo-Miller et al., 1999). Such a rise
in presynaptic calcium levels could be due to the activation of
the PLC pathway (Reichardt, 2006), which in turn could activate
calcium influx mediated by TRPC channels (Amaral and Pozzo-
Miller, 2007b) and/or release of calcium from intracellular stores
(Amaral and Pozzo-Miller, 2012).
The presynaptic actions of BDNF also may involve synapsins,
a family of proteins that associate with synaptic vesicles and
regulate the release of various neurotransmitters (Hilfiker et al.,
1999; Gitler et al., 2004, 2008; Cesca et al., 2010; Kile et al.,
2010; Song and Augustine, 2016). Synapsins are encoded by
three mammalian genes, which generate multiple isoforms
through alternative splicing. Deletion of the genes for either
synapsin I or synapsin II (Jovanovic et al., 2000), as well as all
three synapsins (Kao et al., 2017), attenuates the presynaptic
response to BDNF, implicating synapsins in BDNF enhancement
of glutamate release. Each synapsin isoform contains sites for
phosphorylation by several protein kinases, including MAPK
(Hilfiker et al., 2005), and these sites have been implicated
as downstream substrates for MAPK phosphorylation during
BDNF signaling (Jovanovic et al., 2000).
To differentiate the roles of synapsins and calcium in the
presynaptic actions of BDNF, we employed synapsin triple-
knockout (TKO) mice (Gitler et al., 2004), ion substitution
and pharmacological approaches. We identified two parallel
pathways, involving both TRPC-channel mediated calcium
influx and MAPK-mediated synapsin phosphorylation, that
make kinetically distinct contributions to BDNF enhancement
of spontaneous glutamate release. The TRPC-mediated pathway
also enhances spontaneous release of GABA, though this effect is
normally inhibited by synapsins under physiological conditions.
MATERIALS AND METHODS
Hippocampal Neuronal Cultures
Homozygous synapsin TKO mice and matching triple wild-type
(TWT) mice were produced as described previously (Feng et al.,
2002; Gitler et al., 2004). The procedures used to maintain
and use these mice were approved by the Animal Care and
Use Committees of Duke University and the Biopolis Biological
Resource Center. Newborn pups (postnatal day 0–1) were
used to prepare hippocampal neurons. Microisland cultures of
hippocampal neurons were prepared as described in Bekkers
and Stevens (1991), with the addition of glia feeder cells to
support neuronal survival. Neurons were allowed to mature for
10–14 days before being used for electrophysiological recordings.
In other experiments (calcium imaging, measurements
of spontaneous miniature IPSCs), high-density cultures of
hippocampal neurons (e.g., Bi and Poo, 1998) were prepared and
examined 10–18 days later.
Electrophysiological Acquisition and Data
Analysis
For recording spontaneous mEPSCs, whole-cell patch-clamp
recordings were made from single neurons on microislands.
Patch pipettes (4–6 MΩ) were filled with intracellular solution
containing (in mM): 50 K-glutamate, 71 K-gluconate (Fluka,
Buchs, Switzerland), 15 NaCl, 6 MgCl2, 0.5 EGTA, 5 Na2ATP,
0.3 Na2GTP and 20 HEPES-KOH, pH 7.3 (285 mOsm). The
extracellular solution contained (in mM): 150 NaCl, 3 KCl,
2 CaCl2, 2 MgCl2, 20 glucose and 10 HEPES-NaOH, pH 7.3
(310 mOsm). All materials were from Sigma, unless specified
otherwise. A HEKA EPC-9D amplifier (HEKA, Lambrecht/Pfalz,
Germany) was used to voltage clamp neurons at a holding
potential of −70 mV. Under these conditions, spontaneous
EPCSs are solely due to mEPSCs that were blocked by the
AMPA receptor antagonist, CNQX (20 µM). Spontaneous
synaptic events were semi-automatically analyzed using the
MiniAnalysis program (Synaptosoft, Decatur, GA, USA). Values
were compared by the Student’s t test, with error bars shown
in the figures indicating the SEM. BDNF was purchased from
Peprotech (Rock Hill, NJ, USA) and BDNF-containing external
solution was delivered via air pressure (3–5 psi; Picospritzer,
General Valve, Firfield, NJ, USA) from a glass pipette (tip
diameter 30–50 µm) placed 100 µm away.
Similar procedures were used to record spontaneous
miniature IPSCs, the intracellular solution contained (in mM):
140 CsCl, 4 NaCl, 0.5 CaCl2, 5 EGTA, 2 MgATP, 0.4 Na3GTP,
10 HEPES-KOH and 10 QX-314 (pH 7.4, adjusted with CsOH).
The holding potential for mIPSC recordings was also −70 mV.
mIPSCs were recorded in the presence of tetrodotoxin (1 µM),
APV (50 µM) and CNQX (20 µM) to eliminate action potentials
and excitatory postsynaptic currents. Under these conditions,
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the responses must be mIPSCs. All recordings were made at
room temperature (21–25◦C).
Calcium Imaging
To identify presynaptic terminals, neurons were transfected
with a synaptophysin-mCherry plasmid (a generous gift from
Dr. M. Kennedy, Duke University) via lipofectamine transfection
at day 4–6, with neurons imaged at days 10–14. The calcium
indicator dye Fluo4-AM (1 µM; Invitrogen, CA, USA) was
then loaded into the neurons at 37◦C for 30 min. Neurons
were imaged after 30 additional minutes of incubation in
dye-free solution. In these experiments, the external solution
contained 10 µM CNQX, 25 µM APV and 1 µM TTX to
prevent calcium signals associated with glutamate receptors or
action potentials. Images of identified presynaptic terminals
were acquired before and during 5 min application of BDNF.
Presynaptic terminals were identified as structures with punctate
synaptophysin-mCherry fluorescence signals <2 µm2 in area.
Images were viewed through a 40×, 0.7 NA objective of an
inverted epifluorescence microscope (IX70, Olympus) equipped
with a mercury lamp; dye excitation was controlled by a
mechanical shutter (Uniblitz). The optical filters used for
imaging Fluo4 were 470 ± 20 nm (excitation), 505 nm
(dichroic mirror), and 530 ± 20 nm (emission); for mCherry
these were 540 ± 10 nm (excitation), 570 nm (dichroic
mirror), and 590 nm long pass (emission). All filters were
obtained from Chroma Technologies, Rockingham, VT, USA.
Images were obtained with a back-illuminated, cooled CCD
camera with the on-chip multiplication gain control (Cascade
512B, Photometrics, Tucson, AZ, USA). Images were acquired
and analyzed by RatioTool software (ISee Imaging Systems,
Raleigh, NC, USA). Fluo4 measurements were made from
15–20 presynaptic boutons in each experiment.
RESULTS
We used cultured hippocampal neurons to examine the signaling
pathways underlying the acute presynaptic actions of BDNF.
BDNF-Mediated Calcium Influx via TRPC
Channels
Although several studies have demonstrated a BDNF-induced
rise in intracellular calcium concentration ([Ca2+]i), these
measurements were made from neuronal cell bodies or dendritic
spines (Li et al., 1998; Amaral and Pozzo-Miller, 2007b, 2012).
To determine whether presynaptic [Ca2+]i levels are also
affected by BDNF, we began by using fluorescence imaging
to directly monitor [Ca2+]i in presynaptic terminals. To
identify these terminals, we transfected neurons with a plasmid
encoding a synaptic vesicle protein, synaptophysin, fused to
the red fluorescent protein mCherry. After transfection for
5–6 days, synaptophysin-mCherry distributed in a punctuate
pattern consistent with localization of its native counterpart to
presynaptic terminals (Kennedy and Ehlers, 2011). We then
used a low-affinity fluorescent calcium indicator dye, Fluo4-AM,
FIGURE 1 | Brain-derived neurotrophic factor (BDNF) induced calcium
rise at presynaptic terminals. (A) Representative images of presynaptic
terminals from triple wild-type (TWT) neurons transfected with
synaptophysin-mCherry (red) after Fluo4-AM loading (green). Images of
Fluo4 fluorescence during 1st (left) and 5th minute (right) of BDNF application
in the absence (B) and presence of SKF96365 (C). Scale at right indicates
relative changes in Fluo4 fluorescence relative to baseline levels measured
prior to BDNF treatment (∆F/F0). (D) Time course of BDNF-induced rise in
presynaptic calcium, measured in control conditions (black) and in the
presence of SKF96365 (red).
to measure [Ca2+]i changes in such synaptophysin-mCherry
labeled terminals (Figure 1A).
Presynaptic [Ca2+]i, as indicated by Fluo4 fluorescence,
increased upon application of BDNF (Figure 1B). The
BDNF-induced rise in [Ca2+]i was modest in amplitude
(Figure 1D), with the peak change of 0.07 ± 0.02 (n = 7),
corresponding to a volume-averaged [Ca2+]i rise of
approximately 100 nM. This rise in [Ca2+]i was transient,
reaching a peak within 30 s and then slowly returning to
baseline levels by the end of a 5-min long application of BDNF
(Figure 1D). This indicates that BDNF does indeed elevate
[Ca2+]i in presynaptic terminals.
Because calcium influx through TRPC3 channels has been
implicated in the actions of BDNF (Amaral and Pozzo-Miller,
2007b, 2012), and these channels co-localize with several
presynaptic markers (Singh et al., 2004), we next asked whether
the BDNF-mediated rise in presynaptic [Ca2+]i is mediated by
TRPC channels.We examined the actions of SKF96365, a blocker
of store-operated cation channels including TRPC channels
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(Merritt et al., 1990; Zhu et al., 1998), on the BDNF-induced
rise in presynaptic [Ca2+]i. Pretreatment of neurons with
SKF96365 greatly reduced the rise in presynaptic [Ca2+]i caused
by BDNF (Figures 1C,D). This drug reduced the peak change in
Fluo4 signal caused by BDNF from 0.07 ± 0.02 to 0.02 ± 0.01
(n = 6; p < 0.01, Student’s t-test), while the fluorescence signal
integrated over the first 120 s of BDNF application was reduced
from 8.2 ± 2.4 ∆F/F.s in control conditions to 0.6 ± 0.4 ∆F/F.s
in the presence of SKF96365 (p < 0.03, Student’s t-test). This
indicates that the majority of the presynaptic [Ca2+]i signal
associated with BDNF is due to Ca2+ influx through TRPC or
a similar store-operated cation channel.
Role of Calcium Influx in BDNF
Enhancement of Glutamate Release
To examine the role of TRPC-mediated Ca2+ influx in the
regulation of spontaneous glutamate release by BDNF (Lessmann
et al., 1994; Li et al., 1998), we measured mEPSCs in microisland-
cultured hippocampal neurons. Treatment of these neurons with
BDNF increased the frequency of mEPSCs (Figure 2A). This
response consisted of two kinetically-distinct components: an
initial, transient rise that reached a peak within 1 min and
a secondary, sustained increase in mEPSC frequency that was
sustained throughout the entire 5-min long application of BDNF
(Figure 2B, black symbols). To quantify the effect of BDNF, we
measured the relative increase in mEPSC frequency during the
1st minute of BDNF application, representing the transient initial
component, and during the 5th minute of BDNF application,
FIGURE 2 | Role of calcium influx in BDNF enhancement of
spontaneous glutamate release. (A) Representative traces of miniature
EPSCs before and during BDNF application from a WT autaptic neuron.
(B) Time course of changes in normalized miniature excitatory postsynaptic
current (mEPSC) frequency during BDNF application (bar) in normal external
solution (black) and calcium-free external solution (orange, n = 6).
(C) Changes in mEPSC frequency during 1st (left) and 5th (right) minute of
BDNF application. Throughout the article, values indicate mean ± standard
error of the mean and ∗denotes a significant difference (p < 0.05).
to assess the sustained component (Figure 2C, black). The
increase in mEPSC frequency occurring during the first minute
of BDNF application was 157 ± 29% (mean ± SEM) and
was approximately half as large (89 ± 34%) after 5 min of
BDNF treatment. In addition to this acute presynaptic action
of BDNF, we asked whether BDNF exerts a postsynaptic effect
by measuring the amplitude of mEPSCs. We found that the
amplitude of mEPSCs did not change significantly during a
5-min long application of BDNF; mean mEPSC amplitude was
25.8 ± 2.6 pA in control conditions and 25.6 ± 2.2 pA in
the presence of BDNF. Therefore, though BDNF is known
to increase mEPSC amplitude when applied for longer times
(Levine et al., 1998), our data indicate that the initial locus of
action of BDNF at glutamatergic synapses is presynaptic under
our conditions.
To determine whether the BDNF-induced Ca2+ influx shown
in Figure 1 is involved in the increase in mEPSC frequency, we
examined the actions of BDNF in a calcium-free external solution
containing the Ca2+ chelator EGTA (Figure 2B, orange). In
this condition, the initial BDNF-induced increase in mEPSC
frequency was reduced significantly to 33% of control (n = 8;
p< 0.03, Student’s t-test), while the secondary sustained increase
in mEPSC frequency was unaffected (135% of control, p = 0.43,
Figure 2C). This indicates that the initial component of the
BDNF response at least partially requires Ca2+ influx, while
the sustained component does not. Similar to the Ca2+ influx
induced by BDNF, the initial BDNF-induced increase in mEPSC
FIGURE 3 | TRPC3 mediates spontaneous glutamate release by BDNF.
(A) Changes in mEPSC frequency caused by BDNF application in the
absence (black, n = 13) and presence of SKF95365 (green, n = 6).
(B) Changes in mEPSC frequency during 1st (left) and 5th (right) minute of
BDNF application in control conditions and during treatment with SKF96365.
(C) Changes in mEPSC frequency caused by BDNF application in the
absence (black, n = 5) and presence of Pyr3 (sky blue, n = 5). (D) Changes in
mEPSC frequency during 1st (left) and 5th (right) minute of BDNF application
in control conditions and during treatment with Pyr3.
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frequency was reduced to 33% of control (n = 8, p = 0.02)
by SKF96365 (Figures 3A,B, green). In contrast, the sustained
component was not significantly affected by SKF96365 (89%
of control, p = 0.67; Figure 3B). Furthermore, Pyr3, a more
specific blocker of TRPC3 channels (Kiyonaka et al., 2009)
almost entirely eliminated the initial BDNF-induced increase
in mEPSC frequency (12% of control, n = 5, p = 0.03) but
spared the sustained component (178% of control, n = 5,
p = 0.43; Figures 3C,D, cyan). In sum, it appears that the
initial presynaptic response to BDNF involves Ca2+ influx via
TRPC3 channels, while the sustained component does not.
Role of MAPK Pathway
Given that the MAPK pathway has been implicated in the
presynaptic actions of BDNF (Jovanovic et al., 1996), we next
determined the role of this kinase by examining the effects of
the MAPK inhibitor U0126. Treatment with this compound
completely prevented the sustained enhancement of mEPSC
frequency by BDNF (−3% of control, n = 9, p = 0.001), while also
reducing the transient initial component of the BDNF response
(Figure 4A). The residual increase in mEPSC frequency (17%
of control) was transient, returning to baseline during the first
2 min of BDNF treatment (Figure 4A). Quantification revealed
the absence of a sustained response and a reduction in the
initial response to BDNF in the presence of U0126 (Figure 4B,
blue). Thus, the MAPK pathway seems to be responsible for the
FIGURE 4 | MAP kinase (MAPK)-dependent and calcium-dependent
responses to BDNF. (A) Time course of changes in normalized mEPSC
frequency during BDNF application in the absence and presence of the MAPK
inhibitor, U0126 (20 µM). U0126 was bath perfused 5 min prior BDNF
application. (B) Changes in mEPSC frequency during 1st (left) and 5th (right)
minute of BDNF application, with and without U0126. (C) Time course of
changes in normalized mEPSC frequency in neurons in normal external
solution (black) or in calcium-free solution containing EGTA and U0126 (aqua).
(D) Changes in mEPSC frequency during 1st (left) and 5th minute (right) of
BDNF application in the indicated conditions.
sustained response to BDNF but not for the transient, initial
response.
Taken together, our results suggest that TRPC3-mediated
Ca2+ influx is involved in the transient, initial component
of the BDNF response while the MAPK pathway is involved
in the late, sustained component. If this is the case, then
blocking both Ca2+ influx and MAPK activity should completely
abolish the ability of BDNF to enhance spontaneous glutamate
release. Indeed, when neurons were treated with U0126 in
Ca2+-free external solution, BDNF failed to increase mEPSC
frequency (Figure 4C). Both the transient initial component
(−1% of control, n = 6, p = 0.01, Figure 4D, aqua) and
the sustained response to BDNF (5% of control, n = 6,
p = 0.001, Figure 4D, aqua) were absent in these conditions.
We therefore conclude that Ca2+ influx via TRPC3 channels
mediates the transient, initial BDNF response while MAPK
mediates the late, sustained response. Further, we can conclude
that these two signaling pathways together are completely
responsible for the presynaptic actions of BDNF under our
conditions.
Synapsin Involvement in MAPK Pathway
Having identified the kinetic components associated with
Ca2+ influx and MAPK activation, we next could assess the
contribution of synapsins as potential MAPK substrates. For
this purpose, we cultured neurons from synapsin TKO mice
(Gitler et al., 2004) and examined their responses to BDNF.
FIGURE 5 | Role of synapsins in MAPK pathway. (A) Time course of
changes in normalized mEPSC frequency during BDNF application for TWT
(black, n = 13) and synapsin triple knock-out (TKO) neurons (red, n = 12).
(B) Changes in mEPSC frequency during 1st (left) and 5th minute (right) of
BDNF application in TWT and TKO neurons. (C) Time course of changes in
normalized mEPSC frequency during BDNF application in TKO neurons in the
absence (red) or presence (purple) of U0126. (D) Changes in mEPSC
frequency during 1st (left) and 5th minute (right) of BDNF application in TKO
neurons with and without U0126 treatment.
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The dual-pathway model we have proposed predicts that TKO
neurons would exhibit the transient, initial response to BDNF
but not the late, sustained response. The BDNF response of TKO
neurons was greatly attenuated (Figure 5A). Indeed, as predicted
the sustained BDNF response was completely abolished (−5%
of control, n = 12, p < 0.001), while the transient response
was reduced but preserved (20% of control, n = 12, p = 0.01,
Figure 5B, red). The residual transient response to BDNF
observed in the TKO neurons was remarkably similar, both in
magnitude and in time course, to the response of WT neurons
after blockade of the MAPK pathway (compare to Figure 4A).
This is consistent with the hypothesis that synapsins are the
main substrates of MAPK in mediating the sustained response to
BDNF. Further support for this notion come from experiments
where TKO neurons were treated with U0126: under these
conditions, U0126 caused no change in the BDNF response
(Figure 5C). Neither the initial, transient component (84%
of control, n = 5, p = 0.19) nor the sustained component
67% of control, p = 0.28) of TKO neurons were affected by
U0126 treatment (Figure 5D). This occlusion of the effect of
the MAPK inhibitor strongly implicates synapsins as the major
substrates for MAPK in mediating the sustained presynaptic
response to BDNF.
In TKO neurons there was a residual initial component of
BDNF response both in the presence and the absence of MAPK
activity. According to our model, this component is mediated
FIGURE 6 | Role of calcium influx in the BDNF response of synapsin
TKO neurons. Either removal of calcium (A) or inhibiting TRPC channels
(C) abolished the residual increase in mEPSC frequency produced in TKO
neurons by BDNF. Data from TKO neurons in normal (red, n = 12) and
calcium-free external solution (brown) shown in (A); data from TKO neurons in
the absence (red) and presence of SKF95365 (green, n = 6) shown in (C).
(B) Changes in mEPSC frequency during 1st (left) and 5th minute (right) of
BDNF application in TKO neurons in normal and calcium free solution.
(D) Changes in mEPSC frequency during 1st (left) and 5th minute (right) of
BDNF application in TKO neurons in the absence or presence of
SKF95365 and Pyr3 (sky blue, n = 6).
by the BDNF-activated Ca2+ influx pathway. We tested this
hypothesis by treating TKO neurons with Ca2+-free external
solution. In such conditions, the BDNF-induced transient
increase in mEPSC frequency was completely eliminated (−20%
of control, n = 7, p = 0.02, Figures 6A,B, brown). This
indicates that the initial, transient increase in mEPSC frequency
of TKO neurons requires an influx of external Ca2+. Further,
this component was abolished following blockade of TRPC
channels by SKF96365 (13% of control, n = 6, p = 0.048; t-test,
analyses of variance (ANOVA) followed by Tukey’s post hoc test,
p = 0.03, Figures 6C,D, green) and blockade of TRPC3 channels
by Pyr3 (10% of control, n = 6, p = 0.02, t-test; ANOVA
followed by Tukey’s post hoc test, p = 0.025, Figures 6C,D,
cyan). Thus, the synapsin-independent transient response to
BDNF requires Ca2+ influx through TRPC3 channels. We
therefore conclude that the presynaptic actions of BDNF can
be explained by two parallel signaling pathways: the initial,
transient response is mediated by influx of external Ca2+
through TRPC3 channels, while the slower, persistent response
is mediated by MAPK phosphorylation of synapsins. These
conclusions are summarized in Figure 7.
BDNF Regulation of GABA Release
BDNF reportedly has variable acute effects on GABA release
(Frerking et al., 1998; Bolton et al., 2000; Wardle and Poo, 2003;
Canas et al., 2004; Shinoda et al., 2014). We revisited the acute
actions of BDNF on spontaneous GABA release, specifically
to determine whether the model for presynaptic signaling we
developed for acute BDNF regulation of spontaneous glutamate
release (Figure 7) is applicable to BDNF regulation of GABA
release. For this purpose, miniature IPSCs (mIPSCs) were
recorded in high-density cultures of hippocampal neurons and
FIGURE 7 | Dual signaling pathway model for BDNF action at
glutamatergic synapses.
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FIGURE 8 | BDNF regulation of spontaneous GABA release.
(A) Representative miniature IPSCs before and during BDNF application,
recorded in TWT neurons (left) and TKO neurons (right). (B) Time course of
changes in normalized miniature inhibitory postsynaptic current (mIPSC)
frequency during BDNF application for TWT (black, n = 21) and synapsin TKO
neurons (red, n = 18). (C) Changes in mIPSC frequency during 1st (left) and
6th minute (right) of BDNF application.
BDNFwas applied for 6min. In TWTneurons, mIPSC frequency
was unaffected by BDNF (Figures 8A–C). Similarly, BDNF
did not affect mIPSC amplitude, which was 29.6 ± 1.7 pA
in control conditions and 29.9 ± 1.7 pA in the presence
of BDNF. These results are consistent with previous reports
that application of BDNF for 5–6 min does not affect mIPSC
frequency or amplitude (Shinoda et al., 2014; Colino-Oliveira
et al., 2016). However, in synapsin TKO neurons, BDNF
application increased mIPSC frequency (Figure 8A). The time
course of this GABAergic presynaptic response to BDNF
was slower than that of spontaneous glutamate release, with
mIPSC frequency gradually increasing over the entire time
of BDNF application (Figure 8B). As a result, there was
no increase in mIPSC frequency during the 1st minute of
BDNF application (Figure 8C) but a significant increase in
mIPSC frequency in TKO neurons (36% of TWT; n = 18)
in comparison to TWT neurons (−1 ± 3% change; n = 21)
after 6 min of BDNF treatment. Because there was no initial
increase in mIPSC frequency, in subsequent figures we measured
only the increase in mIPSC during the final minute of the
6-min long application of BDNF. In TWT neurons, BDNF
caused no significant change in mIPSC amplitude, which was
28.5 ± 0.9 pA in control conditions and 28.7 ± 0.9 pA in
the presence of BDNF. These results indicate that BDNF has
a covert ability to regulate spontaneous GABA release that is
observed after genetic deletion of synapsins. Thus, spontaneous
glutamate and GABA release are differentially regulated by
BDNF: synapsins play a positive role in BDNF signaling in
glutamatergic terminals and a negative role in GABAergic
terminals.
FIGURE 9 | MAPK-independent BDNF effects on spontaneous GABA
release. (A) Time course of changes in normalized mIPSC frequency during
BDNF application for TWT neurons without (black, n = 21) and with (orange,
n = 10) MAPK inhibitor U0126 (20 µM). (B) Changes in mIPSC frequency
during 6th minute of BDNF application in TWT neurons, with and without
U0126 treatment. (C) Time course of changes in normalized mIPSC frequency
in TKO neurons during BDNF application without (red, n = 18) and with (green,
n = 10) U0126 treatment. (D) Changes in mIPSC frequency in TKO neurons
during 6th minute of BDNF application, with and without U0126.
To evaluate the role of the MAPK pathway in regulation of
spontaneous GABA release, we examined the effect of U0126 on
mIPSC frequency during BDNF application. In TWT neurons,
BDNF had no effect on mIPSC frequency in the presence of the
MAPK inhibitor (Figures 9A,B). Thus, even though synapsins
appear to inhibit BDNF signaling in these neurons, blockade
of MAPK signaling does not affect this inhibition. Similarly,
the BDNF-induced increase in mIPSC frequency observed in
TKO neurons was unaffected, in time course (Figure 9C) or in
magnitude (Figure 9D), by the MAPK inhibitor. This indicates
that the synapsin-independent increase in spontaneous GABA
release observed in TKO neurons also is not regulated by the
MAPK pathway.
Given the role of MAPK- and synapsin-independent Ca2+
influx in BDNF regulation of spontaneous glutamate release
(Figure 7), we hypothesized that such influx might also mediate
the BDNF response of TKO neurons. To test this hypothesis,
we examined the effect of BDNF in Ca2+-free external
solution. In TWT neurons, mIPSC frequency was unaffected by
BDNF in Ca2+-free conditions (Figures 10A,B). However, the
BDNF-induced increase in mIPSC frequency observed in TKO
neurons was completely abolished (Figure 10C). Instead, BDNF
caused a mild decrease in mIPSC frequency in these conditions
(Figure 10D). This indicates that BDNF increases spontaneous
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FIGURE 10 | Role of calcium influx in presynaptic action of BDNF on
spontaneous GABA release in TKO neurons. (A) Time course of changes
in normalized mIPSC frequency during BDNF application for TWT neurons in
normal (black, n = 21) and calcium-free gray, n = 14) external solution.
(B) Changes in mIPSC frequency in TWT neurons during 6th minute of BDNF
application in normal and calcium-free external solution. (C) Time course of
changes in normalized mIPSC frequency in TKO neurons during BDNF
application in normal (red, n = 18) and calcium-free (blue, n = 13) external
solution. (D) Changes in mIPSC frequency in TKO neurons during 6th minute
of BDNF application, in the absence and presence of external calcium.
GABA release in TKO neurons by causing Ca2+ influx, similar
to the case for the initial component of the BDNF-mediated
increase in spontaneous glutamate release.
Finally, we asked whether this BDNF-induced Ca2+ influx
is carried by TRPC3 channels. BDNF had no effect on
mIPSC frequency in TWT neurons treated with SKF96365
(Figures 11A,B, olive). In contrast, SFK96365 completely
abolished the ability of BDNF to increase mIPSC frequency in
TKOneurons (Figures 11C,D, turquoise). Pyr3 also inhibited the
increase in mIPSC frequency caused by BDNF in TKO neurons
(Figures 11E,F, cyan). We therefore conclude that the ability of
BDNF to increase spontaneous GABA release in TKO neurons is
caused by Ca2+ influx through TRPC3 channels. This is similar to
the case for BDNF regulation of spontaneous glutamate release,
except the former is sustained for at least 6 min (Figure 8B),
while the latter is transient and lasts for approximately 2 min
(Figure 5A).
DISCUSSION
BDNF regulates synaptic transmission and synaptic plasticity
in multiple ways. We have studied one of the most prominent
effects of this neurotrophin, the enhancement of spontaneous
transmitter release from presynaptic terminals. Our study
provides new insights into the intracellular signaling pathways
that mediate BDNF action at presynaptic terminals.
Two Parallel Pathways for BDNF
Presynaptic Action
We found that BDNF employs two parallel pathways to
increase spontaneous glutamate release and that these pathways
mediate responses with different kinetics. Specifically, a
TRPC3-mediated Ca2+ influx pathway is responsible for
FIGURE 11 | Role of TRPC channels in presynaptic action of BDNF on
spontaneous GABA release in TKO neurons. (A) Time course of changes
in normalized mIPSC frequency during BDNF application for TWT neurons
without (black, n = 21) and with (olive green, n = 12) SKF96365 (3 µM).
(B) Changes in mIPSC frequency during 6th minute of BDNF application in
TWT neurons, with and without SKF96365 treatment. (C) Time course of
changes in normalized mIPSC frequency in TKO neurons during BDNF
application without (red, n = 18) and with (turquoise, n = 12)
SKF96365 treatment. (D) Changes in mIPSC frequency in TKO neurons
during 6th minute of BDNF application, with and without SKF96365. (E) Time
course of changes in normalized mIPSC frequency in TKO neurons during
BDNF application without (red, n = 18) and with (sky blue, n = 8)
Pyr3 treatment (3 µM). (F) Changes in mIPSC frequency in TKO neurons
during 6th minute of BDNF application, with and without Pyr3.
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an initial, transient increase in mEPSC frequency, while
MAPK-mediated phosphorylation of synapsins is required for
the sustained enhancement of mEPSC frequency in response
to BDNF. These two components together are sufficient
to completely account for the ability of BDNF to enhance
spontaneous glutamate release. We found that BDNF can also
influence spontaneous GABA release via TRPC3-mediated
Ca2+ influx, though normally this pathway is inhibited by
synapsins.
At glutamatergic synapses, there is some temporal overlap
between the transient response, which begins almost immediately
and subsides within 1–2 min (e.g., Figures 4A, 5A), and the
sustained response, which gradually rises from the start of
BDNF application and only reaches a peak 2–4 min later
(e.g., Figures 2B, 3A,C). This temporal overlap is emphasized
whenmeasuring responses after 1min of BDNF treatment, which
is why conditions that eliminate the sustained component have
some effect on responses measured at 1 min (Figures 4B, 5B)
and why conditions that eliminate the transient component
do not completely eliminate the response measured at 1 min
(Figures 2C, 3B,D). However, this overlap does not change the
conclusion that these two components of BDNF response are
distinct and can be differentiated by their transient or sustained
characteristics.
TRPC Channels and the Transient Initial
Response to BDNF
Our analysis of the effect of BDNF on spontaneous glutamate
release revealed an initial component of BDNF response that
is experimentally distinct from the sustained, MAPK- and
synapsin-dependent component. The initial component was
attenuated by removal of external Ca2+ and by treatment with
blockers of TRPC3 channels and, thus, is mediated by Ca2+ influx
through TRPC3 channels. This conclusion is consistent with the
results of previous pharmacological experiments (Amaral and
Pozzo-Miller, 2012) that did not specify which TRPC isoform
was involved. Although BDNF is known to activate several
TRPC family members—including TRPC3 (Amaral and Pozzo-
Miller, 2007b), TRPC5 (Fortin et al., 2012), and TRPC6 (Zhou
et al., 2008) our study has established that the TRPC3 channel
mediates BDNF-induced spontaneous glutamate and GABA
release. Our results are consistent with a previous report that
TRPC3 channels are present in presynaptic terminals (Singh
et al., 2004).
Further support for the involvement of a Ca2+ influx pathway
in the transient initial response to BDNF comes from the
observation that the kinetics of this component—as determined
in conditions where the other component is abolished, for
example in synapsin TKOneurons (Figure 5)—had a time course
very similar to that of the transient rise in presynaptic [Ca2+]i
induced by BDNF treatment (Figure 1). While BDNF previously
has been shown to increase [Ca2+]i in the soma and dendrites
of hippocampal neurons (Amaral and Pozzo-Miller, 2007a,b;
Nakata and Nakamura, 2007; Li et al., 2010), ours is the first
direct demonstration of a BDNF-induced rise in [Ca2+]i within
presynaptic terminals. Although the rise in presynaptic [Ca2+]i
produced by BDNF is modest, on the order of 100 nM, this
is quantitatively sufficient to cause the 50% increase in mEPSC
frequency observed (Ravin et al., 1999; Angleson and Betz,
2001; Schneggenburger and Rosenmund, 2015). We therefore
propose that the initial enhancement of mEPSC frequency by
BDNF is caused by the rise in presynaptic [Ca2+]i that we
observed.
MAPK and Synapsins Mediate the
Sustained Response to BDNF
The MAPK-synapsin pathway has previously been implicated
in the presynaptic actions of BDNF (Jovanovic et al., 1996,
2000, 2001; Kao et al., 2017). In addition, this pathway has
been shown to regulate both long-term and short-term synaptic
plasticity (Jovanovic et al., 2001; Kushner et al., 2005; Chin
et al., 2006). A role for synapsins I and II in BDNF-evoked
glutamate release was established via measurements of glutamate
release from synaptosomes; in these experiments, the response
to BDNF was abolished in synaptosomes prepared from the
brains of synapsin I/II knockout mice (Jovanovic et al., 2000).
Very recently, it was reported that the ability of BDNF
to enhance spontaneous glutamate release is abolished in
neurons from synapsin I/II/III TKO mice, where the possible
contributions of every synapsin isoform can be excluded
(Kao et al., 2017). By examining the kinetics of the BDNF
response of glutamatergic neurons, we could determine that
deletion of all synapsins abolished the sustained enhancement
of mEPSC frequency caused by BDNF, consistent with the
results of previous experiments. Further, we could discern a
smaller, initial component of BDNF response mediated by Ca2+
influx.
Because synapsins are well-established substrates of MAPK,
we propose that MAPK works upstream of synapsins in this
pathway by phosphorylating synapsins (Figure 7). Our main
experimental support for this proposal is that application of
a MAPK inhibitor, which completely eliminated the sustained
response to BDNF in TWT neurons, had no effect in synapsin
TKO neurons (Figures 5C,D). However, the synapsin isoforms
involved remains to be determined. Among the five main
mammalian synapsin isoforms, only synapsins Ia, Ib and
IIIa have experimentally determined MAPK phosphorylation
sites. Synapsin I isoforms are likely to be important for the
presynaptic BDNF response, because BDNF causes synapsin
Ia to be phosphorylated at MAPK phosphorylation sites
Ser 62, Ser 67 and Ser 549 (Jovanovic et al., 1996) and
deletion of the synapsin I gene abolishes the enhancement
of glutamate release by BDNF in synaptosomes (Jovanovic
et al., 2000). It remains possible that isoforms other than
synapsin I may also be involved: the acute enhancement of
evoked EPSCs by BDNF is intact in synapsin I KO neurons, as
well as in synapsin I KO neurons expressing loss-of-function
mutations in synapsin I MAPK phosphorylation sites (S62A,
S67A; Valente et al., 2012). Ser 470 in synapsin IIIa has
also been determined to be a substrate for MAPK (Porton
et al., 2004), though whether this site is phosphorylated in
response to BDNF is not yet known. Further work will
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be needed to identify the key synapsin isoforms, and their
phosphorylation sites, involved in mediating the presynaptic
effects of BDNF.
The mechanism by which the MAPK/synapsin pathway
mediates the enhancement of spontaneous glutamate release by
BDNF also is unknown. Conventionally, synapsins are though
to maintain glutamatergic synaptic vesicles within a reserve pool
(Hilfiker et al., 1999). It is possible that MAPK kinase signaling
enhances mobilization of vesicles from this pool, though the
main synapsin isoform involved in maintaining vesicles within
the reserve pool is synapsin IIa, which is not yet established
as a MAPK substrate (Gitler et al., 2008). Other presynaptic
mechanisms might also be involved, such as alteration of
synaptic vesicle recycling (Chi et al., 2003) or enhancement of
short-term synaptic potentiation, a process thought to result
from enhancement of the readily-releasable pool of synaptic
vesicles (Giachello et al., 2010).
BDNF Regulation of Spontaneous GABA
Release
Previous work has yielded diverse conclusions regarding the
acute effects of BDNF at GABAergic presynaptic terminals.
While application of BDNF for 15–25 min increases mIPSC
frequency (Wardle and Poo, 2003), application of BDNF for
5–10 min reportedly does not increase mIPSC frequency
(Colino-Oliveira et al., 2016). Our results are consistent with
the latter findings: a 6-min long application of BDNF had no
effect on mIPSCs in WT neurons. Thus, the duration of BDNF
exposure is an important variable for regulating spontaneous
GABA release.
Remarkably, even a 6-min long application of BDNF was
sufficient to elevate mIPSC frequency in synapsin TKO neurons.
This response to BDNF was mediated by the same TRPC3-
dependent Ca2+ influx pathway involved in BDNF regulation
of spontaneous glutamate release. Presumably the differences in
the time course of responses in glutamatergic and GABAergic
synapses reflect differences in the gating of TRPC3 channels in
the two types of nerve terminals: the upstream intracellular signal
transduction (e.g., PLC pathway) mediating TRPC3 opening
could be different in the two cases, or perhaps the same signaling
pathway is simply operating on different time scales.
Because BDNF responses were not observed at GABAergic
synapses of WT mice, we conclude that synapsins serve to
prevent BDNF regulation of GABA release via TRPC3 under
normal physiological conditions. This is not the only difference
in synapsin action between glutamatergic and GABAergic
presynaptic terminals: in cultured hippocampal neurons, only
synapsin IIa can rescue defects in glutamatergic vesicle reserve
pool size observed in TKO neurons (Gitler et al., 2008), while
virtually any synapsin isoform can rescue the slowing of GABA
release from the readily releasable pool of GABAergic vesicles
found in TKO neurons (Song and Augustine, 2016). While
we do not understand how synapsins inhibit BDNF signaling
in GABAergic terminals, possible mechanisms include Ca2+-
dependent ATP binding and hydrolysis (Esser et al., 1998;
Hosaka and Südhof, 1998a,b, 1999), mitochondrial localization
and ATP production (Su et al., 2014), or other unknown
enzymatic activity (Kahn and Besterman, 1991; Esser et al., 1998).
In conclusion, our data show that two different signaling
pathways are involved in the presynaptic actions of BDNF.
For glutamatergic presynaptic terminals, a TRPC3-mediated
influx of Ca2+ elevates spontaneous glutamate release by
elevating presynaptic Ca2+ concentration and a second pathway
is based on MAPK-mediated phosphorylation of synapsins
that causes a sustained enhancement of glutamate release via
an unknown mechanism. In contrast, at GABAergic nerve
terminals, synapsins opposes the ability of BDNF to enhance
Ca2+ influx through a TRPC3 channel.
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